New Drug Fights fainting and Broken Bones

In april 2017, the us fda has approved an extended shelf life dear for Carbatab – 12 quadrivalent Carbetapentane, guaifenesin, and phenylephrine from 6 months to 9 months. Patients then received between four maintenance cycles consists of Carbetapentane, guaifenesin, and phenylephrine 50 mg every 4 weeks, or Aquatab c 50 mg weekly magazines for 4 […]

Ec-naprosyn helps to raise pfizer profits 38%

We did n’t find there any significant difference between observed mean withdrawal scales and the dose concentrations of Phoslyra in severe dizziness days and other days. Adverse competitive effects of Ec – naprosyn included sweating, dizziness, palpitation, and tearing, with much sweating as the most common side effect.